Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticancer drug   Mitomycin  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Ametycine France
Crisofimina Argentina
Fatrix Chile
Maximitom Argentina
Maximiton Ecuador
Minazol Colombia
Mitameta Italy
Mitem Germany, Switzerland
Mitocin Brazil
Mitokebir Argentina, Ecuador
Mitolem Colombia, Venezuela
Mitomicina Argentina, Chile, Ecuador, Italy, Mexico, Peru, Portugal, Romania, Spain
Mitomycin Austria, Belgium, Denmark, Finland, Germany, Great Britain, Greece, Hungary, Iran, Ireland, Italy, Malaysia, New Zealand, Norway, Poland, Slovenia, Sweden, Turkey, United States of America
Mitomycine Luxembourg, Netherlands
Mitotie Argentina, Chile, Ecuador, Peru
Mitozytrex United States of America
Mixandex Colombia, Mexico
Mutamycin United States of America
Riptam Colombia
Ronzine Argentina, Peru
Urocin Germany
Stability in solutions   Injection   Stability in solutions : Mitomycin     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 1 mg/ml 2-8°C Protect from light
2 Day
4763
Level of evidence B
Glass Water for Injection 1 mg/ml 20-25°C Protect from light
6 Hour
4763
Level of evidence B
Glass Water for Injection 1 mg/ml 25°C Not specified
24 Hour
1827
Level of evidence A
Conflicting data
Glass Water for Injection 1 mg/ml 25°C Protect from light
8 Hour
3897
Level of evidence B
Conflicting data
Polyvinyl chloride Sodium chloride 0,9% 0.6 mg/ml -30°C Protect from light
30 Day
1239
Level of evidence D
Polypropylen Syringe Water for Injection 0,5 mg/ml 25°C Protect from light
7 Day
648
Level of evidence D
Conflicting data
Polypropylen Syringe Water for Injection 0,5 mg/ml 4°C Protect from light
28 Day
648
Level of evidence D
Polypropylen Syringe Water for Injection 1 mg/ml 25°C Protect from light
8 Hour
3897
Level of evidence B
Conflicting data
Polypropylen Syringe Water for Injection 2 mg/ml 2-8°C Protect from light
8 Hour
4763
Level of evidence B
Polypropylen Syringe Water for Injection 2 mg/ml 20-25°C Protect from light
8 Hour
4763
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,2 mg/ml 2-8°C Protect from light
5 Day
4763
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,2 mg/ml 20-25°C Protect from light
6 Hour
4763
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,2 mg/ml 25°C Protect from light
10 Hour
3897
Level of evidence B
Conflicting data
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml 2-8°C Protect from light
2 Day
4763
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,4 mg/ml 20-25°C Protect from light
6 Hour
4763
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 37°C Not specified
5 Hour
4282

Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml 37°C Not specified
5 Hour
4282

Not specified Water for Injection 0,4 mg/ml -20°C Not specified
23 Day
4367
Level of evidence C
Not specified Water for Injection 0,4 mg/ml 25°C Not specified
24 Hour
4367
Level of evidence C
Not specified Water for Injection 0,4 mg/ml 4°C Not specified
14 Day
4367
Level of evidence C
Not specified Water for Injection 0,6 mg/ml 4°C Protect from light
4 Day
1827
Level of evidence A
Not specified Water for Injection 0,6 & 0,8 mg/ml 25°C Protect from light
4 Day
1827
Level of evidence A
Conflicting data
  Mentions Légales